# Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators

Page: https://stenobird.com/podcast/hematologic-oncology-update-916423/multiple-myeloma-inside-the-issue-of-cereblon-e3-ligase-modulators
Text version: https://stenobird.com/podcast/hematologic-oncology-update-916423/multiple-myeloma-inside-the-issue-of-cereblon-e3-ligase-modulators.md
Podcast: [Hematologic Oncology Update](https://stenobird.com/podcast/hematologic-oncology-update-916423)
Published: 2026-02-18T18:30:00+00:00
Episode link: https://hematologic-oncology.captivate.fm/episode/5921-insidetheissue2025-celmodsmm
Audio file: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/82ec9ebe-d3a4-4183-b673-7124cbe7df83.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/multiple-myeloma-inside-the-issue-of-cereblon-e3-ligase-modulators
Duration seconds: 3478

## Resource

Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations. CME information and select publications here .

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/multiple-myeloma-inside-the-issue-of-cereblon-e3-ligase-modulators/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/hematologic-oncology-update-916423/multiple-myeloma-inside-the-issue-of-cereblon-e3-ligase-modulators.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.